These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30560432)

  • 1. Cystatin C and creatinine-based eGFR levels and their correlation to long-term morbidity and mortality in older adults.
    Werner K; Christensson A; Legrand H; Pihlsgård M; Sterner G; Elmståhl S
    Aging Clin Exp Res; 2019 Oct; 31(10):1461-1469. PubMed ID: 30560432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
    Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
    Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatinine versus cystatin C to estimate glomerular filtration rate in adults with congenital heart disease: Results of the Boston Adult Congenital Heart Disease Biobank.
    Opotowsky AR; Carazo M; Singh MN; Dimopoulos K; Cardona-Estrada DA; Elantably A; Waikar SS; Mc Causland FR; Veldtman G; Grewal J; Gray C; Loukas BN; Rajpal S
    Am Heart J; 2019 Aug; 214():142-155. PubMed ID: 31203159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
    Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
    Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.
    Peralta CA; Lee A; Odden MC; Lopez L; Zeki Al Hazzouri A; Neuhaus J; Haan MN
    J Am Geriatr Soc; 2013 Jan; 61(1):90-5. PubMed ID: 23252993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the utility of cystatin C as a confirmatory test of chronic kidney disease across the age range in middle-aged and older community-dwelling adults.
    Canney M; Sexton DJ; O'Leary N; Healy M; Kenny RA; Little MA; O'Seaghdha CM
    J Epidemiol Community Health; 2018 Apr; 72(4):287-293. PubMed ID: 29332011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of creatinine and cystatin C-based eGFR equations in Chinese older adults with chronic kidney disease.
    Guan C; Liang M; Liu R; Qin S; He F; Li J; Zhu X; Dai H; Fu J
    Int Urol Nephrol; 2018 Dec; 50(12):2229-2238. PubMed ID: 29948865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease, cardiovascular risk markers and total mortality in older men: cystatin C versus creatinine.
    Zonoozi S; Ramsay SE; Papacosta O; Lennon LT; Ellins EA; Halcox JPJ; Whincup P; Wannamethee SG
    J Epidemiol Community Health; 2019 Jul; 73(7):645-651. PubMed ID: 30890591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C-based glomerular filtration rate associates more closely with mortality than creatinine-based or combined glomerular filtration rate equations in unselected patients.
    Helmersson-Karlqvist J; Ärnlöv J; Larsson A
    Eur J Prev Cardiol; 2016 Oct; 23(15):1649-57. PubMed ID: 27037092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score.
    Sharma S; Denburg MR; Furth SL
    Pediatr Nephrol; 2017 Aug; 32(8):1457-1463. PubMed ID: 28484878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.
    Werner K; Pihlsgård M; Elmståhl S; Legrand H; Nyman U; Christensson A
    Nephron; 2017; 137(1):29-37. PubMed ID: 28407629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C.
    Shlipak MG; Katz R; Kestenbaum B; Fried LF; Newman AB; Siscovick DS; Stevens L; Sarnak MJ
    Am J Nephrol; 2009; 30(3):171-8. PubMed ID: 19349699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
    Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
    Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
    J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of estimated glomerular filtration rate by the chronic kidney disease epidemiology collaboration (CKD-EPI) equations with and without Cystatin C for predicting clinical outcomes in elderly women.
    Lim WH; Lewis JR; Wong G; Turner RM; Lim EM; Thompson PL; Prince RL
    PLoS One; 2014; 9(9):e106734. PubMed ID: 25265151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project.
    Rothenbacher D; Rehm M; Iacoviello L; Costanzo S; Tunstall-Pedoe H; Belch JJF; Söderberg S; Hultdin J; Salomaa V; Jousilahti P; Linneberg A; Sans S; Padró T; Thorand B; Meisinger C; Kee F; McKnight AJ; Palosaari T; Kuulasmaa K; Waldeyer C; Zeller T; Blankenberg S; Koenig W;
    BMC Med; 2020 Nov; 18(1):300. PubMed ID: 33161898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid kidney function decline and mortality risk in older adults.
    Rifkin DE; Shlipak MG; Katz R; Fried LF; Siscovick D; Chonchol M; Newman AB; Sarnak MJ
    Arch Intern Med; 2008 Nov; 168(20):2212-8. PubMed ID: 19001197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and determinants of differences in cystatin C and creatinine-based estimated glomerular filtration rate in community-dwelling older adults: a cross-sectional study.
    Legrand H; Werner K; Christensson A; Pihlsgård M; Elmståhl S
    BMC Nephrol; 2017 Dec; 18(1):350. PubMed ID: 29202804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.